Omada Health (NASDAQ:OMDA) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Omada Health (NASDAQ:OMDA) from a hold rating to a buy rating in a research report report published on Saturday.

OMDA has been the topic of several other research reports. Canaccord Genuity Group decreased their price target on Omada Health from $28.00 to $22.00 and set a “buy” rating on the stock in a research note on Friday, March 6th. The Goldman Sachs Group reissued a “buy” rating and set a $26.00 price objective on shares of Omada Health in a report on Friday, January 16th. BMO Capital Markets lowered their target price on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a report on Friday, March 6th. Wells Fargo & Company began coverage on shares of Omada Health in a research report on Thursday, January 8th. They set an “equal weight” rating and a $17.00 target price for the company. Finally, Barclays cut their price target on shares of Omada Health from $22.00 to $17.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Eight equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $23.60.

Omada Health Stock Up 1.9%

Shares of OMDA opened at $14.80 on Friday. The stock has a market cap of $872.09 million and a price-to-earnings ratio of -87.06. Omada Health has a 12 month low of $10.28 and a 12 month high of $28.40. The company has a 50-day moving average price of $13.88 and a two-hundred day moving average price of $18.32.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings data on Thursday, March 5th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.12. The company had revenue of $75.85 million during the quarter.

Insiders Place Their Bets

In other Omada Health news, President Wei-Li Shao sold 5,618 shares of the business’s stock in a transaction on Monday, December 29th. The stock was sold at an average price of $16.13, for a total value of $90,618.34. Following the transaction, the president owned 69,079 shares of the company’s stock, valued at approximately $1,114,244.27. The trade was a 7.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Sean P. Duffy sold 230,479 shares of the firm’s stock in a transaction on Monday, January 12th. The shares were sold at an average price of $15.60, for a total value of $3,595,472.40. Following the completion of the sale, the chief executive officer owned 126,644 shares of the company’s stock, valued at approximately $1,975,646.40. This trade represents a 64.54% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 280,956 shares of company stock worth $4,395,050.

Institutional Investors Weigh In On Omada Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in OMDA. Strs Ohio bought a new position in shares of Omada Health in the third quarter worth about $38,000. Raymond James Financial Inc. bought a new stake in shares of Omada Health during the second quarter valued at approximately $32,000. Quarry LP acquired a new stake in shares of Omada Health in the fourth quarter valued at approximately $29,000. TD Waterhouse Canada Inc. bought a new position in Omada Health in the 4th quarter worth approximately $32,000. Finally, Rakuten Investment Management Inc. bought a new position in Omada Health in the 3rd quarter worth approximately $49,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.